Comments on surviving sepsis guideline 2012

Affiliations

Comment

Supradip Ghosh. Crit Care Med. 2013 Dec.

. 2013 Dec;41(12):e486-7.

doi: 10.1097/CCM.0b013e3182978cc8.

¹ Department of Critical Care Medicine, Fortis Escorts Hospital, NIT, Faridabad, Haryana, India.

No abstract available

Comment in

The authors reply.
Dellinger RP, Jaeschke R. Dellinger RP, et al. Crit Care Med. 2013 Dec;41(12):e487. doi: 10.1097/CCM.0000000000000055. Crit Care Med. 2013. PMID: 24275419 No abstract available.

Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition.
Cheng SS, Nordenholz K, Matero D, Pearlman N, McCarter M, Gajdos C, Hamiel C, Baer A, Luzier E, Tran ZV, Olson T, Queensland K, Lutz R, Wischmeyer P. Cheng SS, et al. Intensive Care Med. 2012 Apr;38(4):642-8. doi: 10.1007/s00134-011-2453-4. Epub 2012 Jan 10. Intensive Care Med. 2012. PMID: 22231174 Clinical Trial.
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Dellinger RP, et al. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. Crit Care Med. 2013. PMID: 23353941